Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
684
datasets available to search
ShareScore release 0.9.0
Dataset results
684 results for “Head and Neck Squamous Cell Carcinoma”
Study of Lonafarnib in Patients With Recurrent Squamous Cell Carcinoma of the Head and Neck (Study P02530)
ClinicalTrials.gov study NCT00073450. IPD Sharing: Not stated. Countries: 0. Publications: 1.
Bempegaldesleukin (NKTR-214) With Radiation and Anti-PD-1 Immunotherapy for Head and Neck Squamous Cell Carcinoma
ClinicalTrials.gov study NCT04936841. IPD Sharing: NO. Countries: 1. Publications: 0.
Radiation and Cetuximab Plus Intratumoral EGFR Antisense DNA in Locally Advanced Head and Neck Squamous Cell Carcinoma
ClinicalTrials.gov study NCT01592721. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Combination of Taxotere and Oxaliplatin in Squamous Cell Carcinoma of the Head and Neck
ClinicalTrials.gov study NCT00184028. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study of AT-101 in Combination With Docetaxel in Squamous Cell Carcinoma Of The Head and Neck
ClinicalTrials.gov study NCT01285635. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Cetuximab and Recombinant Interleukin-12 in Treating Patients With Squamous Cell Carcinoma of the Head and Neck That is Recurrent, Metastatic, or Cannot Be Removed by Surgery
ClinicalTrials.gov study NCT01468896. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Induction Chemotherapy for Locally Advanced Squamous Cell Carcinoma of the Head and Neck
ClinicalTrials.gov study NCT01412229. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study of Atezolizumab Plus Tiragolumab and Atezolizumab Plus Placebo as First-Line Treatment in Participants With Recurrent/Metastatic PD-L1 Positive Squamous Cell Carcinoma of the Head and Neck
ClinicalTrials.gov study NCT04665843. IPD Sharing: YES. Countries: 13. Publications: 0.
AMD3100 Plus Pembrolizumab in Immune Checkpoint Blockade Refractory Head and Neck Squamous Cell Carcinoma
ClinicalTrials.gov study NCT04058145. IPD Sharing: YES. Countries: 1. Publications: 0.
Fractionated Radiation Therapy in Treating Advanced Squamous Cell Carcinoma of the Head and Neck
ClinicalTrials.gov study NCT00771641. IPD Sharing: Not stated. Countries: 0. Publications: 18.
PEmbrolizumab Combined With Chemoradiotherapy in Squamous Cell Carcinoma of the Head and Neck
ClinicalTrials.gov study NCT02819752. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Temporally Feathered Radiation Therapy (TFRT) for Head and Neck Squamous Cell Carcinoma
ClinicalTrials.gov study NCT03768856. IPD Sharing: Not stated. Countries: 1. Publications: 0.
HPV-16 Vaccination and Pembrolizumab Plus Cisplatin for "Intermediate Risk" HPV-16-associated Head and Neck Squamous Cell Carcinoma
ClinicalTrials.gov study NCT04369937. IPD Sharing: NO. Countries: 1. Publications: 0.
Combination Chemotherapy With or Without Erlotinib Hydrochloride in Treating Patients With Metastatic or Recurrent Squamous Cell Carcinoma of the Head and Neck
ClinicalTrials.gov study NCT01064479. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Durvalumab, Tremelimumab and Hypofractionated Radiation Therapy in Treating Patients With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma
ClinicalTrials.gov study NCT03522584. IPD Sharing: NO. Countries: 1. Publications: 0.
Bortezomib With or Without Irinotecan in Treating Patients With Locally Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck
ClinicalTrials.gov study NCT00103259. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Nivolumab, Carboplatin, and Paclitaxel in Treating Patients With Stage III-IV Head and Neck Squamous Cell Carcinoma That Can Be Removed by Surgery
ClinicalTrials.gov study NCT03342911. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Erlotinib, Docetaxel, and Radiation Therapy in Stage III or Stage IV Squamous Cell Carcinoma of the Head and Neck
ClinicalTrials.gov study NCT00720304. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Metformin Hydrochloride and Doxycycline in Treating Patients With Head and Neck Squamous Cell Carcinoma
ClinicalTrials.gov study NCT03076281. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Phase II Trial of Nelfinavir With Concurrent Chemoradiotherapy in Squamous Cell Carcinoma of the Head and Neck
ClinicalTrials.gov study NCT02207439. IPD Sharing: Not stated. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.